ATE223231T1 - Mikroemulsionszubereitung enthaltend eine schwer absorbierbare substanz - Google Patents

Mikroemulsionszubereitung enthaltend eine schwer absorbierbare substanz

Info

Publication number
ATE223231T1
ATE223231T1 AT94912700T AT94912700T ATE223231T1 AT E223231 T1 ATE223231 T1 AT E223231T1 AT 94912700 T AT94912700 T AT 94912700T AT 94912700 T AT94912700 T AT 94912700T AT E223231 T1 ATE223231 T1 AT E223231T1
Authority
AT
Austria
Prior art keywords
microemulsion
micro
preparation containing
emulsion preparation
substance
Prior art date
Application number
AT94912700T
Other languages
English (en)
Inventor
Masao Takahashi
Hiroshi Matsushita
Original Assignee
Inst Advanced Skin Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Advanced Skin Res Inc filed Critical Inst Advanced Skin Res Inc
Application granted granted Critical
Publication of ATE223231T1 publication Critical patent/ATE223231T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT94912700T 1993-04-19 1994-04-19 Mikroemulsionszubereitung enthaltend eine schwer absorbierbare substanz ATE223231T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9143893 1993-04-19
PCT/JP1994/000645 WO1994023749A1 (fr) 1993-04-19 1994-04-19 Preparation en microemulsion contenant une substance difficilement absorbable

Publications (1)

Publication Number Publication Date
ATE223231T1 true ATE223231T1 (de) 2002-09-15

Family

ID=14026380

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94912700T ATE223231T1 (de) 1993-04-19 1994-04-19 Mikroemulsionszubereitung enthaltend eine schwer absorbierbare substanz

Country Status (9)

Country Link
US (1) US5948825A (de)
EP (1) EP0753311B1 (de)
AT (1) ATE223231T1 (de)
AU (1) AU686149B2 (de)
CA (1) CA2160681A1 (de)
DE (1) DE69431310T2 (de)
ES (1) ES2182841T3 (de)
TW (1) TW438603B (de)
WO (1) WO1994023749A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
DE10164531A1 (de) * 2001-12-31 2003-07-17 Pharmatech Gmbh Zubereitung zur Oberflächenanästhesie der Haut
DE10226990A1 (de) * 2002-06-18 2004-03-18 Sanguibiotech Ag Topisch applizierbare Mikro-Emulsionen mit binärer Phasen- und Wirkstoffdifferenzierbarkeit, deren Herstellung und deren Verwendung, insbesondere zur Versorgung der Haut mit bioverfügbarem Sauerstoff
JP2005097517A (ja) * 2003-02-21 2005-04-14 Seiko Epson Corp マイクロカプセル化顔料の製造方法、マイクロカプセル化顔料、水性分散液及びインクジェット記録用インク
EP1667619A4 (de) * 2003-09-19 2007-10-10 Drugtech Corp Pharmazeutisches zufuhrsystem
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
PE20050596A1 (es) * 2003-12-19 2005-10-18 Novartis Ag Microemulsion que comprende un inhibidor renina
US7357957B2 (en) * 2004-05-07 2008-04-15 Fractec Research & Development Inc. Spreadable food product
DE102004049574A1 (de) 2004-10-12 2006-04-20 Doris Dr. Barnikol-Keuten Arzneimittel und System zur perkutanen Arzneistoffverabreichung
JP2006232755A (ja) * 2005-02-25 2006-09-07 Dai Ichi Kogyo Seiyaku Co Ltd 油中水型マイクロエマルション
JP2008540534A (ja) * 2005-05-09 2008-11-20 ドラッグテック コーポレイション 放出調節薬学組成物
US9743680B2 (en) * 2005-10-14 2017-08-29 Wild Flavors, Inc. Microemulsions for use in food and beverage products
WO2007079389A2 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Composition and method of use thereof
EP1968544A2 (de) * 2006-01-05 2008-09-17 Drugtech Corporation Arzneimittel-verabreichungssystem zur bioadhäsion an einer vulvovaginalen oberfläche
CN107080703A (zh) 2006-12-01 2017-08-22 安特里奥公司 肽纳米粒子和其用途
FR2916966B1 (fr) * 2007-06-11 2011-01-14 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
WO2011076207A2 (en) 2009-12-22 2011-06-30 Leo Pharma A/S Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
SG189845A1 (en) 2010-12-01 2013-06-28 Omnis Biotechnology Inc Thixotropic compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20150133543A1 (en) 2012-06-08 2015-05-14 Leo Laboratories Limited Topical gel composition comprising an ingenol derivative and a solvent mixture
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US10729661B2 (en) 2014-12-19 2020-08-04 Sekisui Chemical Co., Ltd. Preparation
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法
CA3107214A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4731384A (en) * 1983-07-01 1988-03-15 Troponwerke Gmbh & Co, Kg Etofenamate formulation
JPS6061535A (ja) * 1983-08-24 1985-04-09 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト 製薬学的組成物
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
JPS60199833A (ja) * 1984-03-26 1985-10-09 Meiji Milk Prod Co Ltd 医薬品、化粧品等用w/o/w型複合エマルジヨンの製造法
JPS6111137A (ja) * 1984-06-26 1986-01-18 Shiseido Co Ltd 油中水型乳化組成物
CA1301642C (en) * 1987-03-30 1992-05-26 Howard Bernard Dawson Chemical formulations
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
JPH078806B2 (ja) * 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
DE69229779T2 (de) * 1991-04-19 1999-12-23 Lds Technologies, Inc. Konvertierbare mikroemulsionsverbindungen
AU667316B2 (en) * 1991-07-26 1996-03-21 Smithkline Beecham Corporation W/O microemulsions
JPH06509577A (ja) * 1991-07-26 1994-10-27 スミスクライン・ビーチャム・コーポレイション W/oミクロエマルジョン
JP3090353B2 (ja) * 1991-09-17 2000-09-18 旭化成工業株式会社 パラチロイドホルモン類含有経鼻投与用乳剤
SG49746A1 (en) * 1992-08-28 1998-06-15 Pharmos Corp Submicron emulsions as ocular drug delivery vehicles
JPH08502492A (ja) * 1992-10-16 1996-03-19 スミスクライン・ビーチャム・コーポレイション 治療用ミクロエマルジョン
JPH08505367A (ja) * 1992-10-16 1996-06-11 スミスクライン・ビーチャム・コーポレイション 医薬用エマルジョン組成物
WO1994008603A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Corporation Compositions
WO1994019000A1 (en) * 1993-02-17 1994-09-01 Smithkline Beecham Corporation Microemulsions containing pharmaceutical compositions
EP0684833A4 (de) * 1993-02-17 1996-09-11 Smithkline Beecham Corp Mikroemulsionen mit therapeutischen peptiden.
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles

Also Published As

Publication number Publication date
WO1994023749A1 (fr) 1994-10-27
EP0753311A1 (de) 1997-01-15
ES2182841T3 (es) 2003-03-16
TW438603B (en) 2001-06-07
AU6513494A (en) 1994-11-08
US5948825A (en) 1999-09-07
EP0753311B1 (de) 2002-09-04
DE69431310D1 (de) 2002-10-10
EP0753311A4 (de) 1997-05-21
CA2160681A1 (en) 1994-10-27
DE69431310T2 (de) 2003-05-22
AU686149B2 (en) 1998-02-05

Similar Documents

Publication Publication Date Title
ATE223231T1 (de) Mikroemulsionszubereitung enthaltend eine schwer absorbierbare substanz
CA2146757A1 (en) Stabilization of fluorocarbon emulsions
AR017716A1 (es) Articulo de manufactura en la forma de un expendedor atomizador operado no-manualmente
DE69915733D1 (de) Kosmetische oder pharmazeutische Zusammensetzung in Form eines Feststoffs, welche verformt werden kann
EP2100601A3 (de) Topische pharmazeutische Schaumzusammensetzung
DE69009175D1 (de) Verwendung eines alkoholfreien Verabreichungssystems für Wirkstoffe, welche oral eingenommen werden.
CA2131477A1 (fr) Composition cosmetique ou dermatologique constituee d'une emulsion huile dans eau a base de globules huileux pourvus d'un enrobage cristal liquide lamellaire
CA2271636A1 (en) Disinfecting microemulsions
KR920703009A (ko) 피부외용 크리임제제
ATE153532T1 (de) Zusammensetzungen, die einen fluorokohlenwasserstoff und eine lipophile/fluorophile organische verbindung enthalten und ihre verwendungen
CA2125408A1 (en) Drug formulations for parenteral use
PL317635A1 (en) Transparent nanoemulsion on the basis of silicone surfactants and application thereof in cosmectic or in dermatological pharmaceutic preparations
ES2137524T3 (es) Emulsiones de fluorocarbono estables inversas y multiples.
CA2141433A1 (en) Nonflammable Mild Odor Solvent Cleaner
AU3881195A (en) Preparation for percutaneous absorption
DE60234286D1 (de) Haarkonditionierungsmittel enthaltend eine Mischung von Fettalkoholen
DE69500027D1 (de) Gelartige kosmetische und/oder dermatologische Zusammensetzung enthaltend hohle Teilchen und eine grosse Menge an Lösungsmittel
ATE101036T1 (de) Aktivitaetspotenziator gegen krebs.
ES2111102T3 (es) Formulaciones cosmeticas y dermatologicas con un contenido activo en acido cis-urocaninico.
JP2000281521A (ja) L−2−オキソチアゾリジン−4−カルボン酸を含有する連続水相を含む組成物
ES2059869T3 (es) Preparado farmaceutico que contiene piroxicam para uso topico.
ATE286732T1 (de) Azelastinhydrochlorid enthaltende zubereitung mit guter perkutaner absorptionsfähigkeit und verringerter hautreizbarkeit
ATE104554T1 (de) Topische praeparate.
ES2076525T3 (es) Lociones y pulverizadores anti-insectos.
JPH0331203A (ja) 猫忌避剤

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties